Does the Clinical Presentation of Secondary Osteosarcoma in Patients Who Survive Retinoblastoma Differ From That of Conventional Osteosarcoma and How Do We Detect Them?
Kim Y, Park JW, Cho HS, Jang WY, Han I, Kim HS.
Clin Orthop Relat Res. 2023 Nov 1;481(11):2154-2163. doi: 10.1097/CORR.0000000000002667. Epub 2023 May 5.
PMID:37145140
From conventional to cutting edge: an exploration of osteosarcoma treatments.
Chemotherapy Regimens for Non-Metastatic Conventional Appendicular Osteosarcoma: A Literature Review Based on the Outcomes.
Soares do Brito J, Santos R, Sarmento M, Fernandes P, Portela J.
Curr Oncol. 2023 Jun 27;30(7):6148-6165. doi: 10.3390/curroncol30070457.
PMID:37504317
A Systematic Review of the Heterogenous Gene Expression Patterns Associated with Multidrug Chemoresistance in Conventional Osteosarcoma.
Mthethwa PG, Marais LC, Ramsuran V, Aldous CM.
Genes (Basel). 2023 Mar 30;14(4):832. doi: 10.3390/genes14040832.
PMID:37107591
The current status of MRI in the pre-operative assessment of intramedullary conventional appendicular osteosarcoma.
Saifuddin A, Sharif B, Gerrand C, Whelan J.
Skeletal Radiol. 2019 Apr;48(4):503-516. doi: 10.1007/s00256-018-3079-1. Epub 2018 Oct 4.
PMID:30288560
Osteosarcoma: Conventional treatment vs. gene therapy.
Tan ML, Choong PF, Dass CR.
Cancer Biol Ther. 2009 Jan;8(2):106-17. doi: 10.4161/cbt.8.2.7385. Epub 2009 Feb 12.
PMID:19098456
Conventional 99mTc-(hydroxy) methylene diphosphate remains useful to predict osteosarcoma response to neoadjuvant chemotherapy: Individual patient data and aggregate data meta-analyses.
Kubo T, Furuta T, Sakuda T, Ochi M, Adachi N.
Medicine (Baltimore). 2018 Dec;97(51):e13308. doi: 10.1097/MD.0000000000013308.
PMID:30572434
Pediatric Osteosarcoma: Pearls and Pitfalls.
Menendez N, Epelman M, Shao L, Douglas D, Meyers AB.
Semin Ultrasound CT MR. 2022 Feb;43(1):97-114. doi: 10.1053/j.sult.2021.05.010. Epub 2021 May 15.